Hemosil Factor Viii Deficient Plasma
Plasma, Coagulation Factor Deficient. 510(k) K110237, from Instrumentation Laboratory CO (Bedford, MA). Product code GJT, class 2.
As of Nov 21, 2026, K110237 is an FDA 510(k) held by Instrumentation Laboratory CO, substantially equivalent on Jul 8, 2011 after 163 days, with no recalls tied to it in FDA's recall database.
- Review time: 163 days
- Recalls: 0
- Cited as a predicate by: 1 device
HemosIL Factor VIII deficient plasma is human plasma, depleted of Factor VIII, which is intended for the in vitro diagnostic quantitative determination of Factor VIII activity in citrated plasma, based on the activated partial thromboplastin time (APTT) assay, on the ACL TOP® Family analyzers.
- Hemosil Factor Viii Deficient PlasmaK034007 · Instrumentation Laboratory CO · Feb 13, 2004
- CRYOcheck Factor VIII Deficient Plasma with VWFK222831 · Precision Biologic, Inc. · Sep 13, 2023
- CRYOcheck Factor VIII Deficient Plasma with VWFK222831 · Precision Biologic, Inc. · Sep 13, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 26, 2011
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7290
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files